Sonnet BioTherapeutics Holdings (SONN) Net earnings per share growth forecast for next year

Symbol and logo of brand Sonnet BioTherapeutics (SONN)

Sonnet BioTherapeutics leverages the FHAB platform to develop precision oncology drugs. The projected growth of net earnings per share for n+1 reflects current price action, where 0.00 captures the current indicator value. The development of new treatment methods is conducted in collaboration with scientific centers, although the speculative status of the micro-cap and the anticipation of the start of phase II trials remain key factors.

SONN - Sonnet BioTherapeutics Holdings Inc. Earnings growth forecast for next year over the range 07/04/2022 - 12/13/2025

Metric breakdowns and analytics for Sonnet BioTherapeutics (SONN)

- price and consensus price forecast:
Analysis of all company metrics:Sonnet BioTherapeutics
Core merchandise of Sonnet BioTherapeutics Holdings Inc.

For Sonnet BioTherapeutics (SONN), which develops precision immunomodulators to combat metastases, this metric reflects market confidence in the commercialization of its scientific research. By analyzing the company's EPS growth benchmark for the coming year, an investor can see the percentage change in expected net profit calculated based on analyst consensus forecasts. Growth in this metric confirms the fundamental resilience of the business, although sharp fluctuations may signal risks in the execution of clinical strategies.

Direct competitors

Net earnings per share growth forecast for next year immunitybio.com|Expected earnings per share growth for next year immunocore.com (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics Inc (JANX)|Expected earnings per share growth for next year Arcus Bio RCUS|Zymeworks Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Corp TNGX|IOVA - Net earnings per share growth forecast for next year|IMTX (immatics.com) - Projected earnings per share growth rate for next year|Xencor Inc. (XNCR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Compass Bio (CMPX)|Expected earnings per share growth for next year REPL|LYEL - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year IPHA (Innate Pharma, S.A.)|Projected earnings per share increase next year PYXS|Earnings growth forecast for next year CGEN (Compugen Ltd.)|Expected earnings per share trend next year IOBT|sutrobio.com - Earnings growth forecast for next year|Expected net earnings per share growth next year MiNK Therapeutics, Inc|Werewolf (HOWL) - Net earnings per share growth forecast for next year|Immix Biopharma Inc. - Expected earnings per share trend next year|ALXO (alxoncology.com) - Earnings growth forecast for next year|Cue Biopharma, Inc. - Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year pdsbiotech.com (PDSB)|MAIA: Net earnings per share change forecast for next year|Liminatus Pharma Inc. - Expected earnings per share growth for next year|LAVA Therapeutics N.V. (LVTX) - Expected net earnings per share growth next year|NXTC - Net earnings per share growth forecast for next year|LPTX: Net earnings per share growth forecast for next year|Intensity Therapeutics (INTS) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Earnings growth forecast for next year|Gritstone bio (GRTS) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year KA|Consensus forecast of earnings per share growth for next year NexImmune Inc|Net earnings per share growth forecast for next year turnstonebio.com TSBX|Consensus forecast of earnings per share growth for next year Vaccinex Inc (VCNX)|HARP - Net earnings per share growth forecast for next year